Dermatologic Therapy

Papers
(The H4-Index of Dermatologic Therapy is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
156
Issue Information72
Macrophage Migration Inhibitory Factor and Gene Polymorphism (rs755622G>C) in Unstable Vitiligo Patients49
Ultraviolet A Combined with Narrow‐Band Ultraviolet B is an Effective Treatment Modality for Early Folliculotropic Mycosis Fungoides and Early Mycosis Fungoides Refractory to Narrow‐Band Ultraviolet B39
Cutaneous lupus erythematosus variants responsive to J anus kinase inhibition38
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al.34
Fat herniation over striae distansea in focal dermal hypoplasia treated with 2940 nm Er: YAG Laser34
Real‐World Guselkumab Response and Drug Survival in Australian Patients With Psoriasis: Results From the Australasian Psoriasis Registry32
Comparison of Green‐Synthesized Silver Nanoparticle Shampoo Created by Moringa and Bergamot Extraction Versus 2% Ketoconazole Shampoo for Scalp Seborrheic Dermatitis: A Prospective, Randomized, Double31
Psoriasiform dermatitis induced by dupilumab successfully treated with upadacitinib31
Two birds with one stone: Successful treatment with methotrexate in a patient with generalized eruptive keratoacanthoma of Grzybowski and rheumatoid arthritis29
Skin‐Protective Effects of DeinoPol‐BRD125, a Microbial Exopolysaccharide From Deinococcus radiodurans , on Epidermal Hydration and Barrier Recovery25
Dermoscopic Differentiation of Actinic Keratosis and Bowen’s Disease: A Model for Challenging Facial High‐Grade Lesions23
Management of Moderate‐to‐Severe Atopic Dermatitis With Systemic Medications: Review and Expert Commentary22
Biologic Therapy for Refractory Pityriasis Rubra Pilaris21
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysis21
Tofacitinib for the Treatment of Refractory Progressive Vitiligo: A Retrospective Case Series20
Prevalence and Systemic Manifestations of PHACE Syndrome: A Systematic Review and Meta‐Analysis20
19
Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication19
0.15713787078857